Yang Gu

753 total citations
50 papers, 502 citations indexed

About

Yang Gu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Hepatology. According to data from OpenAlex, Yang Gu has authored 50 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 13 papers in Hepatology. Recurrent topics in Yang Gu's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Medical Imaging and Pathology Studies (7 papers) and RNA modifications and cancer (5 papers). Yang Gu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Medical Imaging and Pathology Studies (7 papers) and RNA modifications and cancer (5 papers). Yang Gu collaborates with scholars based in China, United States and Vietnam. Yang Gu's co-authors include Lingling Gao, Xianghua Yin, Martin O’Malley, Quanyan Liu, Baiyang Chen, Deliang Guo, J. Turner Vosseller, Jin Huang, Yusha Xiao and Zhisu Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Water Research.

In The Last Decade

Yang Gu

47 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Gu China 14 160 115 102 92 81 50 502
Yasuhiro Yamanaka Japan 13 151 0.9× 52 0.5× 27 0.3× 310 3.4× 73 0.9× 36 517
Bingyu Xiang China 8 219 1.4× 110 1.0× 59 0.6× 216 2.3× 5 0.1× 9 552
Zehava Vadasz Israel 5 262 1.6× 38 0.3× 46 0.5× 52 0.6× 30 0.4× 8 437
John T. Chow United States 8 264 1.6× 122 1.1× 90 0.9× 189 2.1× 33 0.4× 10 599
Margaret Markiewicz United States 13 347 2.2× 56 0.5× 84 0.8× 33 0.4× 14 0.2× 18 671
Chiho Obayashi Japan 13 109 0.7× 76 0.7× 94 0.9× 108 1.2× 3 0.0× 44 498
Daphne Pala Canada 8 300 1.9× 44 0.4× 58 0.6× 44 0.5× 15 0.2× 8 507
Miaojia Zhang China 12 118 0.7× 38 0.3× 42 0.4× 82 0.9× 17 0.2× 23 547
Nobutaka Sato Japan 14 350 2.2× 239 2.1× 153 1.5× 207 2.3× 27 0.3× 48 716
Jacqueline F. Schmitt Australia 10 341 2.1× 55 0.5× 137 1.3× 43 0.5× 8 0.1× 16 562

Countries citing papers authored by Yang Gu

Since Specialization
Citations

This map shows the geographic impact of Yang Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Gu more than expected).

Fields of papers citing papers by Yang Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Gu. The network helps show where Yang Gu may publish in the future.

Co-authorship network of co-authors of Yang Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Gu. A scholar is included among the top collaborators of Yang Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Gu. Yang Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Yang, et al.. (2025). DDIR: Domain-Disentangled Invariant Representation learning for tailored predictions. Knowledge-Based Systems. 319. 113422–113422.
4.
Li, Yong, Ruimin Wang, Shouzhi Yang, et al.. (2025). Plasmonic alloys enhance metabolic fingerprints for rapid diagnosis and classification of myocardial infarction. Nano Today. 62. 102702–102702. 1 indexed citations
5.
Su, Rina, Hua Qian, Wei Li, et al.. (2024). Oral propranolol for the treatment of hemangiomas in high-risk infants: safety and cost analysis of outpatient-initiated therapy. Frontiers in Medicine. 11. 1439449–1439449. 1 indexed citations
6.
Wan, Li, Jing Zhou, Yang Gu, et al.. (2024). Lactylation of RNA m 6 A demethylase ALKBH5 promotes innate immune response to DNA herpesviruses and mpox virus. Proceedings of the National Academy of Sciences. 121(43). e2409132121–e2409132121. 18 indexed citations
7.
Yan, Qin, Yang Gu, Wenjing Huang, et al.. (2024). Lactylation of NAT10 promotes N4‐acetylcytidine modification on tRNASer-CGA-1-1 to boost oncogenic DNA virus KSHV reactivation. Cell Death and Differentiation. 31(10). 1362–1374. 26 indexed citations
8.
Gu, Yang, Hui Shen, Hongbo Wang, et al.. (2022). Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma. Dove Medical Press (Taylor and Francis Group). 4 indexed citations
9.
Wang, Zhaoyang, et al.. (2022). Systemic Methotrexate Treatment in 42 Children with Severe Plaque Psoriasis: A Retrospective Study in China. Dermatology. 238(5). 919–927. 2 indexed citations
10.
Xie, Wei, Pengpeng Liu, Fei Gao, et al.. (2022). Platelet–neutrophil hybrid membrane-coated gelatin nanoparticles for enhanced targeting ability and intelligent release in the treatment of non-alcoholic steatohepatitis. Nanomedicine Nanotechnology Biology and Medicine. 42. 102538–102538. 23 indexed citations
11.
Yu, Chunyang, et al.. (2022). Identification of intrinsic genes across general hypertension, hypertension with left ventricular remodeling, and uncontrolled hypertension. Frontiers in Cardiovascular Medicine. 9. 992284–992284. 1 indexed citations
12.
Gu, Yang, Baiyang Chen, Deliang Guo, et al.. (2022). Up‐Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 3034150–3034150. 13 indexed citations
13.
Liu, Xiaohong, et al.. (2021). A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients. Medicine. 100(29). e26491–e26491. 4 indexed citations
14.
Guo, Deliang, Yang Gu, Pengpeng Liu, et al.. (2021). A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma. Genes & Diseases. 9(4). 845–848. 3 indexed citations
15.
Ma, Dong, Pengpeng Liu, Baiyang Chen, et al.. (2021). A Novel End-to-End Biliary-to-Biliary Anastomosis Technique for Iatrogenic Bile Duct Injury of Strasberg-Bismuth E1-4 Treatment: A Retrospective Study and in vivo Assessment. Frontiers in Surgery. 8. 747304–747304. 3 indexed citations
16.
Wang, Suyu, Zhiyuan Zhang, Yang Gu, et al.. (2021). Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study. Frontiers in Oncology. 11. 726811–726811. 2 indexed citations
17.
Chen, Baiyang, Yusha Xiao, Pengpeng Liu, et al.. (2021). Long noncoding RNA TP53TG1 suppresses the growth and metastasis of hepatocellular carcinoma by regulating the PRDX4/β-catenin pathway. Cancer Letters. 513. 75–89. 31 indexed citations
18.
19.
Liu, Pengpeng, et al.. (2018). PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway. Biomedicine & Pharmacotherapy. 108. 492–499. 19 indexed citations
20.
Gao, Lingling, Yang Gu, & Xianghua Yin. (2016). High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis. PLoS ONE. 11(10). e0164021–e0164021. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026